Focusing on digital therapy for cognitive impairment, pipeline advantages demonstrate scientific research strength
Posted: Mon Feb 17, 2025 7:04 am
Through the prospectus, the author believes that BrainAurora has formed unique technological advantages and moat barriers with its deep accumulation of virtual humans and AI core technologies, and has gained a firstmover advantage in the field of digital therapy.
From the perspective of product pipeline, the company's product pipeline covers the assessment and intervention of various cognitive disorders induced by vascular diseases, neurodegenerative diseases, mental israel phone number list illnesses, and child developmental defects. It can be seen that it has a deep understanding and comprehensive layout in the field of cognitive impairment, which can meet the needs of different patient groups and provide professional help and support for patients with various cognitive impairments.
Taking the core product as an example, the brain function information management platform software system is a medicalgrade digital therapy product based on evidencebased medicine. It is also China's first digital therapy product for cognitive impairment that has obtained regulatory approval.
This alone is enough to show the company's strength in product research and development and clinical verification, and also provides strong guarantee for the authority and reliability of its products.
From the perspective of product pipeline, the company's product pipeline covers the assessment and intervention of various cognitive disorders induced by vascular diseases, neurodegenerative diseases, mental israel phone number list illnesses, and child developmental defects. It can be seen that it has a deep understanding and comprehensive layout in the field of cognitive impairment, which can meet the needs of different patient groups and provide professional help and support for patients with various cognitive impairments.
Taking the core product as an example, the brain function information management platform software system is a medicalgrade digital therapy product based on evidencebased medicine. It is also China's first digital therapy product for cognitive impairment that has obtained regulatory approval.
This alone is enough to show the company's strength in product research and development and clinical verification, and also provides strong guarantee for the authority and reliability of its products.